Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 101–200 of 1,004
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
Hua, W., ten Dijke, P., Kostidis, S., Giera, M., & Hornsveld, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03398-6 · Cited by 238
“Furthermore, fumarate accumulation in FH-deficient renal cancer cells elicited EMT by inhibiting the ten–eleven translocation (TET)-dependent demethylation of the anti-metastatic mRNA miR-200, which suppressed the expression of the EMT transcription factors SNAI2, ZEB1 and ZEB2 [96, 102, 103] (Fig.”
BackgroundCircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Yang, H., Li, X., Meng, Q., Sun, H., Wu, S., Hu, W., Liu, G., Li, X., Yang, Y., & Chen, R. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1139-3 · Cited by 232
Sun, T., Jiao, L., Wang, Y., Yu, Y., & Ming, L. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0167-4 · Cited by 228
Gomez-Casal, R., Bhattacharya, C., Ganesh, N., Bailey, L., Basse, P., Gibson, M., Epperly, M., & Levina, V. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-94 · Cited by 225
“EMT can be activated by TGF-β and other oncogenic pathways (e.g., Src, Ras, Notch) [32,34] and by tumor microenvironment stresses (e.g., hypoxia) [35,36].”
BackgroundRegulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 215
Lee, J., You, J. H., Kim, M.-S., & Roh, J.-L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101697 · Cited by 222
“Considering that ZEB1 is a key molecule to induce EMT [15], we confirmed whether the regulation of ZEB1 expression resulted in the same as that of CDH1.”
ResultHalimu, G., Zhang, Q., Liu, L., Zhang, Z., Wang, X., Gu, W., Zhang, B., Dai, Y., Zhang, H., Zhang, C., et al. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128485 · Cited by 221
Ruscetti, M., Quach, B., Dadashian, E. L., Mulholland, D. J., & Wu, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3476 · Cited by 225
“EMT, in the context of cancer, allows epithelial cancer cells to acquiremigratory and invasive characteristics, aswell as overcome senescence, apoptosis, and anoikis, properties that are essential for tumor cell dissemination and distant metastasis (11).”
Xu, Y., Gao, X. D., Lee, J.-H., Huang, H., Tan, H., Ahn, J., Reinke, L. M., Peter, M. E., Feng, Y., Gius, D., et al. (2014) · Genes & Development · doi:10.1101/gad.241968.114 · Cited by 225
“EMT is induced by the cytokine TGFb and a group of transcription factors, including Twist, Snail, and Zeb1/2 (De Craene and Berx 2013).”
BackgroundEmerging roles of exosomes during epithelial–mesenchymal transition and cancer progression
Greening, D. W., Gopal, S. K., Mathias, R. A., Liu, L., Sheng, J., Zhu, H.-J., & Simpson, R. J. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.008 · Cited by 220
“[5] De Craene B, Berx G.”
BackgroundCancer stem cells: A brief review of the current status
Kuşoğlu, A., & Biray Avcı, Ç. (2019) · Gene · doi:10.1016/j.gene.2018.09.052 · Cited by 221
Zheng, H., Shen, M., Zha, Y.-L., Li, W., Wei, Y., Blanco, M. A., Ren, G., Zhou, T., Storz, P., Wang, H.-Y., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.022 · Cited by 219
“…in cancer progression, it is not surprising that many signaling pathways have been implicated in the regulation of SNAIL gene expression, including transforming growth factor b (TGF-b), the NOTCH and WNT pathways, reactive oxygen species, and hypoxic stress (reviewed by De Craene and Berx, 2013).”
BackgroundZhao, L., Liu, Y., Zhang, J., Liu, Y., & Qi, Q. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1886-5 · Cited by 214
Loss of E-Cadherin-Dependent Cell–Cell Adhesion and the Development and Progression of Cancer
Bruner, H. C., & Derksen, P. W. B. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029330 · Cited by 213
Jie, X.-X., Zhang, X.-Y., & Xu, C.-J. (2017) · Oncotarget · doi:10.18632/oncotarget.18277 · Cited by 208
Ras and Rap1: A tale of two GTPases
Shah, S., Brock, E. J., Ji, K., & Mattingly, R. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.03.005 · Cited by 211
“It is a complex, transient, and reversible process, characterized by the loss of epithelial characteristics (such as cell–cell attachments, adhesion, and apical–basal polarity) and the gain of mesenchymal characteristics (such as increased motility, invasive properties, and a spindle-like morphology) [55].”
BackgroundNon-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Dragomir, M. P., Kopetz, S., Ajani, J. A., & Calin, G. A. (2020) · Gut · doi:10.1136/gutjnl-2019-318279 · Cited by 211
Sarcomatoid renal cell carcinoma: biology, natural history and management
Blum, K. A., Gupta, S., Tickoo, S. K., Chan, T. A., Russo, P., Motzer, R. J., Karam, J. A., & Hakimi, A. A. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-00382-9 · Cited by 203
Ghanbari Movahed, Z., Rastegari-Pouyani, M., Mohammadi, M. H., & Mansouri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108690 · Cited by 208
Kong, J., Sun, W., Li, C., Wan, L., Wang, S., Wu, Y., Xu, E., Zhang, H., & Lai, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.015 · Cited by 208
Denecker, G., Vandamme, N., Akay, Ö., Koludrovic, D., Taminau, J., Lemeire, K., Gheldof, A., De Craene, B., Van Gele, M., Brochez, L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.44 · Cited by 206
“Furthermore, it has recently become clear that during EMT not only epithelial characteristics are abolished, but that cells are reprogrammed to different extents.(32) Mouse embryos deficient in Zeb2 exhibit defects from E8.”
BackgroundSelf-citationCancer cell plasticity: Impact on tumor progression and therapy response
da Silva-Diz, V., Lorenzo-Sanz, L., Bernat-Peguera, A., Lopez-Cerda, M., & Muñoz, P. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.009 · Cited by 203
“(EGF), hepatocyte growth factor (HGF) and NOTCH, induce SNAIL and ZEB1 expression, which in turn reduce the expression of miR-34 and miR-200 in mesenchymal-like cells [69].”
BackgroundMacrophage: A Cell With Many Faces and Functions in Tuberculosis
Ahmad, F., Rani, A., Alam, A., Zarin, S., Pandey, S., Singh, H., Hasnain, S. E., & Ehtesham, N. Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.747799 · Cited by 188
Leon, G., MacDonagh, L., Finn, S. P., Cuffe, S., & Barr, M. P. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.001 · Cited by 198
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Saxena, K., Jolly, M. K., & Balamurugan, K. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100845 · Cited by 206
“EMT is regulated by complex regulatory networks involving transcription factors, miRNAs, growth factors, non-coding RNAs and epigenetic modifiers [56,57].”
BackgroundAnticancer Activity of Propolis and Its Compounds
Forma, E., & Bryś, M. (2021) · Nutrients · doi:10.3390/nu13082594 · Cited by 188
Hsu, D. S.-S., Wang, H.-J., Tai, S.-K., Chou, C.-H., Hsieh, C.-H., Chiu, P.-H., Chen, N.-J., & Yang, M.-H. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.002 · Cited by 192
“A similar change in these histone marks was observed when FaDu cells were treated with transforming growth factor beta (TGFb), a known inducer of Snail expression and EMT (De Craene and Berx, 2013) (Figure S1B).”
The role of TWIST1 in epithelial-mesenchymal transition and cancers
Zhu, Q.-Q., Ma, C., Wang, Q., Song, Y., & Lv, T. (2016) · Tumor Biology · doi:10.1007/s13277-015-4450-7 · Cited by 189
“The EMT program is orchestrated by at least four fundamental regulatory networks: (1) transcriptional control, (2) regulation from small noncoding RNAs, (3) differential splicing, and (4) translational and posttranslational control [30].”
Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition
Mitra, R., Chen, X., Greenawalt, E. J., Maulik, U., Jiang, W., Zhao, Z., & Eischen, C. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01781-0 · Cited by 191
An EMT‐related gene signature for the prognosis of human bladder cancer
Cao, R., Yuan, L., Ma, B., Wang, G., Qiu, W., & Tian, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14767 · Cited by 190
Dong, J., Hu, Y., Fan, X., Wu, X., Mao, Y., Hu, B., Guo, H., Wen, L., & Tang, F. (2018) · Genome Biology · doi:10.1186/s13059-018-1416-2 · Cited by 187
“However, instead of a single binary switch between the full epithelial and full mesenchymal states, EMT is a process that consists of multiple and dynamic intermediate phases.”
BackgroundInfluentialA self‐enforcing CD 44s/ZEB 1 feedback loop maintains EMT and stemness properties in cancer cells
Preca, B., Bajdak, K., Mock, K., Sundararajan, V., Pfannstiel, J., Maurer, J., Wellner, U., Hopt, U. T., Brummer, T., Brabletz, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29642 · Cited by 189
“These include members of the ZFH family (ZEB1 and ZEB2), the bHLH family (E12/47 and Twist) and the snail family (Snail and Slug).(4,5) Expression of ZEB1 promotes metastasis of tumor cells in a mouse xenograft model, indicating a role of ZEB1 in invasion and metastasis of human tumors.”
BackgroundLiu, F., Yuan, J.-H., Huang, J.-F., Yang, F., Wang, T.-T., Ma, J.-Z., Zhang, L., Zhou, C.-C., Wang, F., Yu, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.80 · Cited by 183
Aspuria, P.-J. P., Lunt, S. Y., Väremo, L., Vergnes, L., Gozo, M., Beach, J. A., Salumbides, B., Reue, K., Wiedemeyer, W. R., Nielsen, J., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-21 · Cited by 185
“regulation and has been the subject of intense research, especially in the context of cancer [6].”
BackgroundGlutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Recouvreux, M. V., Moldenhauer, M. R., Galenkamp, K. M. O., Jung, M., James, B., Zhang, Y., Lowy, A., Bagchi, A., & Commisso, C. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200388 · Cited by 181
“It has also been well established that EMT confers resistance to cell death induced by various stimuli, including DNA damage and chemotherapeutic agents (De Craene and Berx, 2013; Vega et al., 2004; Zheng et al., 2015).”
BackgroundHypoxia-induced epithelial to mesenchymal transition in cancer
Hapke, R. Y., & Haake, S. M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.012 · Cited by 178
“This list of EMT-TFs includes SNAIL1–2 (SNAI1–2), TWIST1–2, ZEB1–2, FOXC2, goosecoid, and others, leading to the repression of E-cadherin and other junctional proteins[31,32].”
BackgroundTherapeutic implications of cancer epithelial-mesenchymal transition (EMT)
Cho, E. S., Kang, H. E., Kim, N. H., & Yook, J. I. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-018-01108-7 · Cited by 180
Jeppesen, D. K., Nawrocki, A., Jensen, S. G., Thorsen, K., Whitehead, B., Howard, K. A., Dyrskjøt, L., Ørntoft, T. F., Larsen, M. R., & Ostenfeld, M. S. (2014) · PROTEOMICS · doi:10.1002/pmic.201300452 · Cited by 177
“Epithelial-to-mesenchymal transition (EMT) is a process defined by disconnection of cells from neighboring cells and acquisition of a more mobile mesenchymal and malignant phenotype that enable invasion of the extracellular environment; the initial stage of metastatic progression [42].”
BackgroundLung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
Yousefi, M., Bahrami, T., Salmaninejad, A., Nosrati, R., Ghaffari, P., & Ghaffari, S. H. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0345-5 · Cited by 179
Aberrant Alternative Splicing Is Another Hallmark of Cancer
Ladomery, M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/463786 · Cited by 181
Epithelial–Mesenchymal Transitions
Savagner, P. (2015) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2014.11.021 · Cited by 176
PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
Jiang, M., Zhang, K., Zhang, Z., Zeng, X., Huang, Z., Qin, P., Xie, Z., Cai, X., Ashrafizadeh, M., Tian, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70295 · Cited by 235
Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
Neophytou, C., Boutsikos, P., & Papageorgis, P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00031 · Cited by 173
“During local invasion, breast cancer cells undergo epithelial-to-mesenchymal transition (EMT), a highly orchestrated transcriptional program, initially described during embryonic development, associated with dramatic remodeling of cytoskeleton, loss of apico-basolateral polarity, dissolution of cell–cell junctions, co…”
BackgroundEpigenetics in lung cancer diagnosis and therapy
Mehta, A., Dobersch, S., Romero-Olmedo, A. J., & Barreto, G. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9563-3 · Cited by 170
“Metastasis is a multistep process which involves the dissociation of tumor cells from the epithelium, invasion to the connective tissues, through the adjacent basement membrane, intravasation, and subsequent extravasation and growth at a distant site [42].”
BackgroundWang, K., Ji, W., Yu, Y., Li, Z., Niu, X., Xia, W., & Lu, S. (2018) · Oncogene · doi:10.1038/s41388-018-0311-3 · Cited by 169
“Tumor metastasis is a complicated serial processes of metastatic cascades, including acquiring of motility and invasion, neovascularization and intravasation, survival and anti-anoikis in blood circulation, extravasation, and colonization [22, 23, 43, 44].”
BackgroundMahmoudi, M. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.02.014 · Cited by 167
“The EMT is recognized as one of the key cellular plasticity characteristics during embryonic development [54]; however, it is now well established that the EMT has more critical effects than expected in tumorigenic process, specifically at the metastatic stages [2].”
BackgroundRole of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
Cano, A., Diaz-Lopez, A., & Moreno-Bueno, G. (2014) · Cancer Management and Research · doi:10.2147/cmar.s38156 · Cited by 165
SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition
Hahn, S., Jackstadt, R., Siemens, H., Hünten, S., & Hermeking, H. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.236 · Cited by 165
“The current literature suggests an extensive crosstalk between EMT-inducing transcription factors and miRNAs during the establishment and maintenance of the mesenchymal phenotype of cells (reviewed in Sanchez-Tillo et al , 2012 and De Craene and Berx, 2013).”
Wagner, R. Y., Luciani, F., Cario-André, M., Rubod, A., Petit, V., Benzekri, L., Ezzedine, K., Lepreux, S., Steingrimsson, E., Taieb, A., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.25 · Cited by 166
“Ecad can be downregulated by the expression of negative transcriptional regulators (well know in the context of EMT), and by epigenetic and/or allogenetic regulations (De Craene and Berx, 2013; Larue and Bellacosa, 2005).”
BackgroundGenome‐wide cooperation of EMT transcription factor ZEB 1 with YAP and AP ‐1 in breast cancer
Feldker, N., Ferrazzi, F., Schuhwerk, H., Widholz, S. A., Guenther, K., Frisch, I., Jakob, K., Kleemann, J., Riegel, D., Bönisch, U., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103209 · Cited by 165
“Particularly, FOSL1 has been heavily implicated in the regulation of EMT and metastasis (Shin et al , 2010; Caramel et al , 2013; Desmet et al , 2013; Bakiri et al , 2015) and also in this context has been shown to work in concert with JUN (Tam et al , 2013; Zhao et al , 2014a; Zhang et al , 2016).”
Evolutionary Nonnegative Matrix Factorization Algorithms for Community Detection in Dynamic Networks
Ma, X., & Dong, D. (2017) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2017.2657752 · Cited by 162
“In disease networks, cancer cell migration leads to metastasis, which is critical for cancer progression and therapy [29].”
BackgroundGlaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 182
Boulding, T., McCuaig, R., Tan, A., Hardy, K., Wu, F., Dunn, J., Kalimutho, M., Sutton, C. R., Forwood, J. K., Bert, A. G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17913-x · Cited by 174
“Again, balb/c nude mice were injected subcutaneously into the mammary fat pads with MDA-MB-231 cells and treated by IP injections with: (1) vehicle only control; (2) nab-paclitaxel (30 mg/kg); (3) phenelzine (40 mg/kg); and nab-paclitaxel + phenelzine Figure 4.”
MethodCaught in the cross fire: p53 in inflammation
Cooks, T., Harris, C. C., & Oren, M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu134 · Cited by 162
“Epithelial to mesenchymal transition is yet another manner by which oncogenic mechanisms are manifested under inflammatory conditions (60).”
BackgroundEpithelial‐mesenchymal transition in cancer metastasis through the lymphatic system
Karlsson, M. C., Gonzalez, S. F., Welin, J., & Fuxe, J. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12092 · Cited by 162
“Loss of tight junction proteins including the coxsackie and adenovirus receptor (CXADR) and occludin, are other hallmarks of EMT, and contributes to loss of the epithelial barrier (De Craene and Berx, 2013; Fuxe et al., 2010; Vincent et al., 2009).”
BackgroundKahlert, U. D., Joseph, J. V., & Kruyt, F. A. E. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12085 · Cited by 162
Clinical significance of epithelial‐mesenchymal transition
Steinestel, K., Eder, S., Schrader, A. J., & Steinestel, J. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-17 · Cited by 156
“This repression is maintained throughout further progression of EMT [20].”
BackgroundSato, R., Semba, T., Saya, H., & Arima, Y. (2016) · Stem Cells · doi:10.1002/stem.2406 · Cited by 171
Cancer cells stemness: A doorstep to targeted therapy
Prasad, S., Ramachandran, S., Gupta, N., Kaushik, I., & Srivastava, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.019 · Cited by 179
Scott, C. L., Soen, B., Martens, L., Skrypek, N., Saelens, W., Taminau, J., Blancke, G., Van Isterdael, G., Huylebroeck, D., Haigh, J., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151715 · Cited by 154
“(C and E) One way ANO VA with Bonferroni posttest was used.”
Self-citationYang, L., & Lin, P. C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.001 · Cited by 155
Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1
Zhang, Y., Huang, W., Yuan, Y., Li, J., Wu, J., Yu, J., He, Y., Wei, Z., & Zhang, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01619-6 · Cited by 170
“During EMT, epithelial cells acquire mesenchymal features, beneficial for migration and invasion of cancer cells, and eventually promotes infiltration and metastasis [19].”
BackgroundGuerra, F., Guaragnella, N., Arbini, A., Bucci, C., Giannattasio, S., & Moro, L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00295 · Cited by 167
“Accumulation of fumarate in FH-deficient cells would promote EMT through an epigenetic mechanism: fumarate suppresses the antimetastatic miRNA cluster mir-200ba429 by inhibiting demethylation of a regulatory region, thus resulting in expression of EMT-TFs (39).”
BackgroundInfluentialdbEMT: an epithelial-mesenchymal transition associated gene resource
Zhao, M., Kong, L., Liu, Y., & Qu, H. (2015) · Scientific Reports · doi:10.1038/srep11459 · Cited by 158
Ishii, H., Saitoh, M., Sakamoto, K., Kondo, T., Katoh, R., Tanaka, S., Motizuki, M., Masuyama, K., & Miyazawa, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589432 · Cited by 153
“The EMT process is controlled by four primary regulatory systems: transcriptional control, alternative splicing, noncoding RNA, and post-translational control (5).”
BackgroundIdentification of recurrent regulated alternative splicing events across human solid tumors
Danan-Gotthold, M., Golan‐Gerstl, R., Eisenberg, E., Meir, K., Karni, R., & Levanon, E. Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv210 · Cited by 164
“This may either support previous studies suggesting that these changes reflect the change in the composition of the tissue (more mesenchymal or epithelial cells) or a true epithelial to mesenchymal (EMT) or mesenchymal to epithelial transition (MET) in these types of tumor (46,47).”
ResultJiang, Y., Cao, W., Wu, K., Qin, X., Wang, X., Li, Y., Yu, B., Zhang, Z., Wang, X., Yan, M., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1364-z · Cited by 157
Willier, S. M., Butt, E., & Grünewald, T. G. P. (2013) · Biology of the Cell · doi:10.1111/boc.201300011 · Cited by 161
“EMT describes a crucial developmental step leading to increased cellular motility and diminished adhesion thereby enabling cellular plasticity (De Craene and Berx, 2013).”
BackgroundDietary ω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of Cancer
Merendino, N., Costantini, L., Manzi, L., Molinari, R., D'Eliseo, D., & Velotti, F. (2013) · BioMed Research International · doi:10.1155/2013/310186 · Cited by 147
Lee, C.-C., Lin, J.-C., Hwang, W.-L., Kuo, Y.-J., Chen, H.-K., Tai, S.-K., Lin, C.-C., & Yang, M.-H. (2018) · Nature Communications · doi:10.1038/s41467-018-06268-0 · Cited by 149
Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
Pearson, G. W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050646 · Cited by 172
“modifications that control chromatin accessibility [19].”
BackgroundWang, C., Yang, Z., Xu, E., Shen, X., Wang, X., Li, Z., Heng, Y., Chen, K., Hu, Q., Xia, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.522 · Cited by 171
Perspective of mesenchymal transformation in glioblastoma
Kim, Y., Varn, F. S., Park, S., Yoon, B. W., Park, H. R., Lee, C., Verhaak, R. G. W., & Paek, S. H. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01151-4 · Cited by 185
Transcriptional control of cancer metastasis
Ell, B. J., & Kang, Y. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.06.001 · Cited by 167
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
Mutlu, M., Raza, U., Saatci, Ö., Eyüpoğlu, E., Yurdusev, E., & Şahin, Ö. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1420-5 · Cited by 153
Epigenetic regulation of epithelial–mesenchymal transition
Sun, L., & Fang, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2303-1 · Cited by 159
“A cohort of transcription factors, including two double zinc finger and homeodomain factors (ZEB1/2, the Snail family of zinc finger proteins (SNAI1/2/3), and the family of bHLH factors (TWIST1/2, E12/E47) becomes expressed and alters gene expression patterns [10, 11].”
Yamamoto, N., Kinoshita, T., Nohata, N., Yoshino, H., Itesako, T., Fujimura, L., Mitsuhashi, A., Usui, H., Enokida, H., Nakagawa, M., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2145 · Cited by 154
“Initiation of the EMT requires external signals, such as epidermal growth factor (EGF), fibroblast growth factor (FGF), hepatocyte growth factor (HGF), a�� ��a��������g g��w�h �a����-β �TGF-β) (31).”
Yu, Y., Luo, W., Yang, Z., Chi, J.-R., Li, Y.-R., Ding, Y., Ge, J., Wang, X., & Cao, X. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0818-9 · Cited by 152
Diaferia, G. R., Balestrieri, C., Prosperini, E., Nicoli, P., Spaggiari, P., Zerbi, A., & Natoli, G. (2016) · The EMBO Journal · doi:10.15252/embj.201592404 · Cited by 161
“In addition to ELF3, another TF reported to control epithelial identity in tumors (De Craene & Berx, 2013) and that is activated by KLF5 also in normal development (Bell et al , 2011, 2013), a few other TFs specific to low-grade PDACs (such as FOXQ1 and GRHL2) were downregulated upon KLF5 loss.”
InfluentialTumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
Kim, E. H., Song, H. S., Yoo, S. H., & Yoon, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11372 · Cited by 144
“EMT is essential for cellular invasion and metastasis [22, 23].”
BackgroundRegulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer
Reichert, M., Bakir, B., Moreira, L., Pitarresi, J. R., Feldmann, K., Simon, L., Suzuki, K., Maddipati, R., Rhim, A. D., Schlitter, A. M., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.05.025 · Cited by 147
“EMT appears to be important for tumor initiation (Craene and Berx, 2013).”
BackgroundCrosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
De Francesco, E. M., Maggiolini, M., & Musti, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072011 · Cited by 142
“As mentioned above, Snail represses E-cadherin expression by recruiting different histone-modifying enzymes at the CHD1 promoter [96].”
BackgroundFunctional roles of alternative splicing factors in human disease
Cieply, B. W., & Carstens, R. P. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1276 · Cited by 175
Samatov, T. R., Tonevitsky, A. G., & Schumacher, U. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-107 · Cited by 141
“ZEBs play an important role in normal embryonic development and they are reported to be upregulated in many tumors [10].”
BackgroundYousefi, M., Nosrati, R., Salmaninejad, A., Dehghani, S., Shahryari, A., & Saberi, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0376-6 · Cited by 157
Vimentin–ERK Signaling Uncouples Slug Gene Regulatory Function
Virtakoivu, R., Mai, A., Mattila, E., De Franceschi, N., Imanishi, S. Y., Corthals, G., Kaukonen, R., Saari, M., Cheng, F., Torvaldson, E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2842 · Cited by 139
“The acquisition of EMT characteristics is believed to be one important mechanism, whereby cancer cells achieve increased motility and invasiveness to promote metastasis (4, 5).”
BackgroundChen, A., Beetham, H. G., Black, M. A., Priya, R., Telford, B. J., Guest, J., Wiggins, G. A. R., Godwin, T. D., Yap, A. S., & Guilford, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-552 · Cited by 167
“We found little support for E-cadherin loss being able to initiate an EMT in a nonmalignant genetic background; deletion of CDH1 from MCF10A cells was not associated with the reduction in epithelial markers and the coordinated increase in mesenchymal markers such as CDH2 [44], nor were the EMT regulators TWIST1, TWIST…”
BackgroundHybrid epithelial/mesenchymal phenotype(s): The ‘fittest’ for metastasis?
Jolly, M. K., Mani, S. A., & Levine, H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.001 · Cited by 161
Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments
O'Sullivan, J. N., Lysaght, J., Donohoe, C. L., & Reynolds, J. V. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0069-7 · Cited by 154
Long noncoding RNA HOTAIR involvement in cancer
Wu, Y., Zhang, L., Wang, Y., Li, H., Ren, X., Wei, F., Yu, W., Wang, X., Zhang, L., Yu, J., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2523-7 · Cited by 139
“EMT, which is essential for numerous developmental processes, leads to cancer cells with stem cell-like characteristics, increases resistance to apoptosis and chemotherapy, and is involved in tumor invasion and metastasis [31, 47, 48].”
BackgroundMoon, H.-J., Finney, J., Ronnebaum, T. A., & Mure, M. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.07.003 · Cited by 151
The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation
Haerinck, J., Goossens, S., & Berx, G. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00601-0 · Cited by 156
Self-citationCirculating Tumor Cells: Moving Biological Insights into Detection
Chen, L., Bode, A. M., & Dong, Z. (2017) · Theranostics · doi:10.7150/thno.18588 · Cited by 150
“, SNAIL, TWIST, and ZEB), microRNAs [27], epigenetic machinery [28], and post-translational regulation [29], leading to EMT [1, 21, 26, 29].”
BackgroundCañadas, I., Rojo, F., Taus, Á., Arpí, O., Arumí-Uría, M., Pijuan, L., Menéndez, S., Zazo, S., Dómine, M., Salido, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1330 · Cited by 135
“org Clin Cancer Res; 20(4) February 15, 2014 945”
BackgroundInfluentialSànchez‐Tilló, E., Fanlo, L., Siles, L., Montes‐Moreno, S., Moros, A., Chiva‐Blanch, G., Estruch, R., Martínez, A., Colomer, D., Győrffy, B., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.123 · Cited by 139
“In malignant epithelial cells, ZEB1 triggers an epithelial-tomesenchymal transition (EMT), a process by which cancer cells acquire a pro-invasive phenotype.(36,37) Consequently, in”
BackgroundEpithelial-to-mesenchymal transition in tumor progression
Prieto‐García, E., Díaz-García, C. V., García‐Ruíz, I., & Agulló-Ortuño, M. T. (2017) · Medical Oncology · doi:10.1007/s12032-017-0980-8 · Cited by 153
“Also, newly published studies have highlighted the essential role of microRNA in the mediation of EMT process by regulating the inducers expression [7, 62].”
BackgroundZEBs: Novel Players in Immune Cell Development and Function
Scott, C. L., & Omilusik, K. D. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.03.001 · Cited by 136
Liu, Y., Yang, M., Luo, J., & Zhou, H. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-00087-0 · Cited by 147
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B
Qiu, G., Xie, X., Xu, F., Shi, X., Wang, Y., & Deng, L. (2014) · Cytotechnology · doi:10.1007/s10616-014-9761-9 · Cited by 161
Carpenter, R. L., Paw, I., Dewhirst, M. W., & Lo, H. (2014) · Oncogene · doi:10.1038/onc.2013.582 · Cited by 143
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.